KRYS Covered Call Strategy
KRYS (Krystal Biotech, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
Krystal Biotech, Inc. is a clinical-stage biotechnology company focused on developing redosable gene therapies to address severe orphan diseases across the United States. Its most advanced therapeutic candidate, beremagene geperpavec (B-VEC), is currently undergoing Phase III clinical evaluation for the treatment of dystrophic epidermolysis bullosa. The company's pipeline also includes several other promising programs: KB105 is in Phase I/II clinical trials for patients suffering from deficient autosomal recessive congenital ichthyosis; KB301 is also in Phase I/II development, aiming to ameliorate wrinkles and other signs of aging or damaged skin. Additionally, Krystal Biotech is conducting preclinical research on KB407 for cystic fibrosis and KB104 for Netherton syndrome. In its earlier discovery phase, the company is exploring candidates such as KB5xx for chronic skin conditions and multiple KB3xx programs targeting aesthetic dermatological concerns. Krystal Biotech, Inc. was established in 2015 and is based in Pittsburgh, Pennsylvania.
KRYS (Krystal Biotech, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $9.81B, a trailing P/E of 40.71, a beta of 0.53 versus the broader market, a 52-week range of 136.73-382.535, average daily share volume of 384K, a public-listing history dating back to 2017, approximately 295 full-time employees. These structural characteristics shape how KRYS stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.53 indicates KRYS has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure. The trailing P/E of 40.71 is on the rich side, which tends to correlate with higher earnings-window IV expansion as the market debates whether forward growth supports the multiple.
What is a covered call on KRYS?
A covered call pairs long stock with a short out-of-the-money call, collecting premium and capping upside above the short strike in exchange for income.
KRYS snapshot
As of August 14, 2026, spot at $331.50, ATM IV 35.60%, IV rank 4.37%, expected move 10.21%. The covered call on KRYS below is built from the August 14, 2026 end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 35-day expiry.
Why this covered call structure on KRYS specifically: KRYS IV at 35.60% is on the cheap side of its 1-year range, which means a premium-selling KRYS covered call collects less credit per unit of strike-width risk, with a market-implied 1-standard-deviation move of approximately 10.21% (roughly $33.83 on the underlying). The 35-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated KRYS expiries trade a higher absolute premium for lower per-day decay. Position sizing on KRYS should anchor to the underlying notional of $331.50 per share and to the trader's directional view on KRYS stock.
KRYS covered call setup
The KRYS covered call below is built from the August 14, 2026 end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With KRYS at $331.50 on that close, the first option leg uses a $350.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed KRYS chain at a 35-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 KRYS shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 100 shares | Stock | $331.50 | long |
| Sell 1 | Call | $350.00 | $7.75 |
KRYS covered call risk and reward
- Net Premium / Debit
- -$32,375.00
- Max Profit (per contract)
- $2,625.00
- Max Loss (per contract)
- -$32,374.00
- Breakeven(s)
- $323.75
- Risk / Reward Ratio
- 0.081
Max profit equals short-strike minus cost basis plus premium times 100; max loss is cost basis minus premium (at zero). Breakeven is cost basis minus premium.
KRYS covered call payoff curve
Modeled P&L at expiration across a range of underlying prices for the covered call on KRYS. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
| Underlying Price | % From Spot | P&L at Expiration |
|---|---|---|
| $0.01 | -100.0% | -$32,374.00 |
| $73.31 | -77.9% | -$25,044.46 |
| $146.60 | -55.8% | -$17,714.92 |
| $219.90 | -33.7% | -$10,385.39 |
| $293.19 | -11.6% | -$3,055.85 |
| $366.49 | +10.6% | +$2,625.00 |
| $439.78 | +32.7% | +$2,625.00 |
| $513.08 | +54.8% | +$2,625.00 |
| $586.37 | +76.9% | +$2,625.00 |
| $659.67 | +99.0% | +$2,625.00 |
When traders use covered call on KRYS
Covered calls on KRYS are an income strategy run on existing KRYS stock positions; traders typically sell calls at 25-35 delta with 30-45 days to expiration to balance premium against upside cap.
KRYS thesis for this covered call
The market-implied 1-standard-deviation range for KRYS extends from approximately $297.67 on the downside to $365.33 on the upside. A KRYS covered call collects premium on an existing long KRYS position, trading off upside above the short call strike for immediate income; the short strike selection should reflect the trader's view on whether KRYS will breach that level within the expiration window. Current KRYS IV rank near 4.37% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on KRYS at 35.60%. As a Healthcare name, KRYS options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to KRYS-specific events.
KRYS covered call positions are structurally neutral to slightly bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. KRYS positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move KRYS alongside the broader basket even when KRYS-specific fundamentals are unchanged. Short-premium structures like a covered call on KRYS carry tail risk when realized volatility exceeds the implied move; review historical KRYS earnings reactions and macro stress periods before sizing. Always rebuild the position from current KRYS chain quotes before placing a trade.
Frequently asked questions
- What is a covered call on KRYS?
- A covered call on KRYS is the covered call strategy applied to KRYS (stock). The strategy is structurally neutral to slightly bullish: A covered call pairs long stock with a short out-of-the-money call, collecting premium and capping upside above the short strike in exchange for income. With KRYS stock at $331.50 on the August 14, 2026 close, the strikes shown on this page are snapped to the nearest listed KRYS chain strike and the premiums come straight from that session's bid/ask midpoint.
- How are KRYS covered call max profit and max loss calculated?
- Max profit equals short-strike minus cost basis plus premium times 100; max loss is cost basis minus premium (at zero). Breakeven is cost basis minus premium. For the KRYS covered call priced from the August 14, 2026 end-of-day chain at a 30-day expiry (ATM IV 35.60%), the computed maximum profit is $2,625.00 per contract and the computed maximum loss is -$32,374.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a KRYS covered call?
- The breakeven for the KRYS covered call priced on this page is roughly $323.75 at expiration, derived from the August 14, 2026 end-of-day chain's premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The KRYS market-implied 1-standard-deviation expected move in the same options snapshot is approximately 10.21%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a covered call on KRYS?
- Covered calls on KRYS are an income strategy run on existing KRYS stock positions; traders typically sell calls at 25-35 delta with 30-45 days to expiration to balance premium against upside cap.
- How does current KRYS implied volatility affect this covered call?
- KRYS ATM IV is at 35.60% with IV rank near 4.37%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.